We are live on ! Find out more
KRYS icon

Krystal Biotech
KRYS

108 hedge funds and large institutions have $836M invested in Krystal Biotech in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

34% more capital invested

Capital invested by funds: $623M → $836M (+$213M)

13% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 31

10% more funds holding

Funds holding: 98 → 108 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.88% less ownership

Funds ownership: 73.48% → 70.6% (-2.9%)

Holders
108
Holders Change
+10
Holders Change %
+10.2%
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
35
Reduced
31
Closed
10
Calls
$2.53M
Puts
–
Net Calls
+$2.53M
Net Calls Change
+$3.58M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10.5M
2
Fidelity International
Fidelity International
Bermuda
+$9.01M
3
RG
Redmile Group
California
+$8.64M
4
JP Morgan Chase
JP Morgan Chase
New York
+$7.67M
5
DP
DSAM Partners
United Kingdom
+$4.38M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$22.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.18M
4
SFM
Sphera Funds Management
Israel
-$4.17M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
FIA
51
FNY Investment Advisers
New York
$1.27M +$499K +10,000 +90%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$1.23M – – –
GECH
53
Garnet Equity Capital Holdings
New York
$1.2M -$999K -20,000 -50%
State of Wisconsin Investment Board
54
State of Wisconsin Investment Board
Wisconsin
$1.13M -$9.99K -200 -1%
HWM
55
HighMark Wealth Management
Minnesota
$1.05M -$65.3K -1,308 -7%
JGC
56
J. Goldman & Co
New York
$985K -$862K -17,254 -51%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$907K +$71.7K +1,435 +10%
UBS Group
58
UBS Group
Switzerland
$848K +$109K +2,192 +18%
Wells Fargo
59
Wells Fargo
California
$839K -$566K -11,337 -45%
Deutsche Bank
60
Deutsche Bank
Germany
$832K +$35.4K +709 +5%
AllianceBernstein
61
AllianceBernstein
Tennessee
$798K – – –
Morgan Stanley
62
Morgan Stanley
New York
$663K +$361K +7,238 +190%
UBS AM
63
UBS AM
Illinois
$640K – – –
SCM
64
Soleus Capital Management
Connecticut
$625K +$521K +10,423 New
Jane Street
65
Jane Street
New York
$624K +$520K +10,406 New
JAMONY
66
Jacob Asset Management of New York
California
$594K +$494K +9,900 New
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$503K +$30.2K +604 +8%
Allianz Asset Management
68
Allianz Asset Management
Germany
$478K -$2.35K -47 -0.6%
Principal Financial Group
69
Principal Financial Group
Iowa
$454K +$378K +7,570 New
SEI Investments
70
SEI Investments
Pennsylvania
$450K – – –
Marshall Wace
71
Marshall Wace
United Kingdom
$446K +$371K +7,427 New
GGHC
72
Gilder Gagnon Howe & Co
New York
$407K -$18.1K -363 -5%
MAM
73
Martingale Asset Management
Massachusetts
$403K -$1.38M -27,700 -81%
ProShare Advisors
74
ProShare Advisors
Maryland
$362K +$302K +6,038 New
DekaBank Deutsche Girozentrale
75
DekaBank Deutsche Girozentrale
Germany
$361K +$320K +6,400 New
1 2
3
4 5

KRYS Hedge Fund Activity: Q4 2020 in Review

108 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Krystal Biotech (KRYS) for Q4 2020, worth a combined $836M — up 34% from $623M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new KRYS positions and 10 closed out — a net gain of 10 holders — while 35 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $10.5M. The largest seller was Victory Capital Management, exiting entirely with an estimated $22.6M sold.

  • 108 institutional investors held Krystal Biotech (KRYS) as of Q4 2020, up from 98 in Q3 2020.
  • Funds reported $836M of Krystal Biotech stock for Q4 2020, up 34% quarter-over-quarter.
  • 20 funds opened new Krystal Biotech positions in Q4 2020 and 10 closed out, a net change of +10 holders.
  • The largest Krystal Biotech buyer in Q4 2020 was BlackRock, an estimated $10.5M added.
  • The largest Krystal Biotech seller in Q4 2020 was Victory Capital Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q4 2020.